Screening for metabolic risk among patients with severe mental illness and diabetes: A national comparison

Psychiatric Services

Volumn 64, Issue 10, 2013, Pages 1060-1063

  Mitchell, Alex J ^a   Hardy, Sheila Ann ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NORTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL PATIENT; PRIMARY MEDICAL CARE; RISK FACTOR; SCREENING TEST; UNITED KINGDOM;

ADULT; CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; GREAT BRITAIN; HUMANS; MASS SCREENING; MENTAL DISORDERS;

EID: 84885452854     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201200514     Document Type: Article

References (15)

1. De Hert M, Dekker JM, Wood D, et al: Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24: 412-424, 2009
2. Mitchell AJ, Vancampfort D, Sweers K, et al: Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders: a systematic review and meta-analysis. Schizophrenia Bulletin 39: 306-318, 2011
3. Vancampfort D, Vansteelandt K, Correll CU, et al: Prevalence of metabolic syndrome and metabolic abnormalities in bipolar disorders: a systematic review and meta- Analysis. American Journal of Psychiatry 170: 265-274, 2013
4. Manu P, Correll CU, van Winkel R, et al: Prediabetes in patients treated with antipsychotic drugs. Journal of Clinical Psychiatry 73: 460-466, 2012
5. Chiu CC, Chen CH, Chen BY, et al: The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine. Progress in Neuro- Psychopharmacology and Biological Psychiatry 34: 866-870, 2010
6. De Hert M, Vancampfort D, Correll CU, et al: Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. British Journal of Psychiatry 199: 99-105, 2011
7. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists, et al: Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 27: 596-601, 2004
8. Quality and Outcomes Framework Guidance for GMS Contract 2012-2013. London, British Medical Association. Available at bma.org.uk/practical-support- at-work/contracts/independent-contractors/qofguidance.
9. Hardy S, Hinks P, Gray R: Screening for cardiovascular risk in patients with severe mental illness in primary care: a comparison with patients with diabetes. Journal of Mental Health 22: 42-50, 2013
10. Shrivastava A, Johnston M, Bureau Y: Stigma of mental illness: 2. noncompliance and intervention. Mena Sana Monographs 1: 85-97, 2012
11. Mitchell AJ, Delaffon V, Vancampfort D, et al: Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychological Medicine 42: 125-147, 2012
12. Osborn DP, Baio G, Walters K, et al: Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care: cohort study in the United Kingdom THIN Primary Care Database 2000-2007. Schizophrenia Research 129: 104-110, 2011
13. Druss BG, von Esenwein SA, Compton MT, et al: A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. American Journal of Psychiatry 167: 151-159, 2010
14. Himelhoch S, Daumit G: To whom do psychiatrists offer smoking-cessation counseling? American Journal of Psychiatry 160: 2228-2230, 2003
15. Bernardo M, Cañas F, Banegas JR, et al: Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area. European Psychiatry 24: 431-441, 2009